Literature DB >> 30544228

Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Masaru Obokata1, Yogesh N V Reddy1, Vojtech Melenovsky1,2, Sorin Pislaru1, Barry A Borlaug1.   

Abstract

AIMS: Prevalent right ventricular (RV) dysfunction (RVD) is associated with increased mortality in patients with heart failure with preserved ejection fraction (HFpEF), but no study has characterized long-term changes in RV structure and function within the same patient. METHODS AND
RESULTS: Patients with unequivocal HFpEF defined by either invasive haemodynamics or hospitalization for pulmonary oedema (n = 271) underwent serial echocardiographic evaluations >6 months apart. Clinical, structural, functional, and haemodynamic characteristics were examined. Over a median of 4.0 years (interquartile range 2.1-6.1), there was a 10% decline in RV fractional area change and 21% increase in RV diastolic area (both P < 0.0001). These changes greatly exceeded corresponding changes in the left ventricle. The prevalence of tricuspid regurgitation increased by 45%. Of 238 patients with normal RV function at Exam 1, 55 (23%) developed RVD during follow-up. Development of RVD was associated with both prevalent and incident atrial fibrillation (AF), higher body weight, coronary disease, higher pulmonary artery and left ventricular filling pressures, and RV dilation. Patients with HFpEF developing incident RVD had nearly two-fold increased risk of death (adjusted hazard ratio 1.89, 95% confidence interval 1.01-3.44; P = 0.04).
CONCLUSION: While previous attention has centred on the left ventricle in HFpEF, these data show that right ventricular structure and function deteriorate to greater extent over time when compared with changes in the left ventricle. Further study is required to evaluate whether interventions targeting modifiable risk factors identified for incident RVD, including abnormal haemodynamics, AF, coronary disease, and obesity, can prevent RVD and thus improve outcomes. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; HFpEF; Heart failure; Pulmonary hypertension; Right ventricle; Tricuspid regurgitation

Mesh:

Year:  2019        PMID: 30544228      PMCID: PMC7963126          DOI: 10.1093/eurheartj/ehy809

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  40 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Garvan C Kane; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

3.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Authors:  Barry A Borlaug; Masaru Obokata
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

4.  Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.

Authors:  Thomas M Gorter; Dirk J van Veldhuisen; Adriaan A Voors; Yoran M Hummel; Carolyn S P Lam; Rolf M F Berger; Joost P van Melle; Elke S Hoendermis
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-04-01       Impact factor: 6.875

5.  Effects of volume loading during experimental acute pulmonary embolism.

Authors:  I Belenkie; R Dani; E R Smith; J V Tyberg
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

Review 6.  Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Authors:  Thomas M Gorter; Dirk J van Veldhuisen; Johann Bauersachs; Barry A Borlaug; Jelena Celutkiene; Andrew J S Coats; Marisa G Crespo-Leiro; Marco Guazzi; Veli-Pekka Harjola; Stephane Heymans; Loreena Hill; Mitja Lainscak; Carolyn S P Lam; Lars H Lund; Alexander R Lyon; Alexandre Mebazaa; Christian Mueller; Walter J Paulus; Burkert Pieske; Massimo F Piepoli; Frank Ruschitzka; Frans H Rutten; Petar M Seferovic; Scott D Solomon; Sanjiv J Shah; Filippos Triposkiadis; Rolf Wachter; Carsten Tschöpe; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2017-10-16       Impact factor: 15.534

7.  Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

Authors:  Michael A Burke; Daniel H Katz; Lauren Beussink; Senthil Selvaraj; Deepak K Gupta; Justin Fox; Sudarsana Chakrabarti; Andrew J Sauer; Jonathan D Rich; Benjamin H Freed; Sanjiv J Shah
Journal:  Circ Heart Fail       Date:  2013-12-23       Impact factor: 8.790

8.  Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Authors:  Dalane W Kitzman; Peter Brubaker; Timothy Morgan; Mark Haykowsky; Gregory Hundley; William E Kraus; Joel Eggebeen; Barbara J Nicklas
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

9.  The hemodynamic basis of exercise intolerance in tricuspid regurgitation.

Authors:  Mads J Andersen; Rick A Nishimura; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2014-09-04       Impact factor: 8.790

10.  Right ventricular remodeling and dysfunction with subsequent annular dilatation and tethering as a mechanism of isolated tricuspid regurgitation.

Authors:  Hye-Sun Seo; Jong-Won Ha; Jae Youn Moon; Eui-Young Choi; Se-Joong Rim; Yangsoo Jang; Namsik Chung; Won-Heum Shim; Seung-Yun Cho; Sung Soon Kim
Journal:  Circ J       Date:  2008-08-27       Impact factor: 2.993

View more
  44 in total

Review 1.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

2.  The year in cardiology: heart failure.

Authors:  John G F Cleland; Alexander R Lyon; Theresa McDonagh; John J V McMurray
Journal:  Eur Heart J       Date:  2020-03-21       Impact factor: 29.983

3.  The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Brandon Wiley; Katlyn E Koepp; Caitlin C Jorgenson; Alexander Egbe; Vojtech Melenovsky; Rickey E Carter; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

4.  Impact of transcatheter mitral valve repair using MitraClip on right ventricular remodeling.

Authors:  Jakob Ledwoch; Carmen Fellner; Petra Hoppmann; Ruth Thalmann; Hans Kossmann; Michael Dommasch; Ralf Dirschinger; Anja Stundl; Karl-Ludwig Laugwitz; Christian Kupatt
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-13       Impact factor: 2.357

5.  Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.

Authors:  Jennifer E Ho; Margaret M Redfield; Gregory D Lewis; Walter J Paulus; Carolyn S P Lam
Journal:  Circulation       Date:  2020-11-02       Impact factor: 29.690

6.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 7.  The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment.

Authors:  Barry A Borlaug; Yogesh N V Reddy
Journal:  JACC Heart Fail       Date:  2019-07       Impact factor: 12.035

8.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.

Authors:  Yogesh N V Reddy; Masaru Obokata; Frederik H Verbrugge; Grace Lin; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-09-01       Impact factor: 24.094

Review 9.  Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.

Authors:  Sanjiv J Shah; Barry A Borlaug; Dalane W Kitzman; Andrew D McCulloch; Burns C Blaxall; Rajiv Agarwal; Julio A Chirinos; Sheila Collins; Rahul C Deo; Mark T Gladwin; Henk Granzier; Scott L Hummel; David A Kass; Margaret M Redfield; Flora Sam; Thomas J Wang; Patrice Desvigne-Nickens; Bishow B Adhikari
Journal:  Circulation       Date:  2020-03-23       Impact factor: 29.690

10.  Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction.

Authors:  Katlyn E Koepp; Masaru Obokata; Yogesh N V Reddy; Thomas P Olson; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2020-07-08       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.